
2 Reasons Why Nostalgia Has A Unique Scent — By A Psychologist
Here's how your sense of smell holds the key to your most vivid and emotional memories.
When the aroma of freshly baked cookies wafts through the air, suddenly, you're back in your grandmother's kitchen. You're a child once more, gazing at those golden treats in anticipation.
This nostalgic journey is your brain's way of responding to the powerful connection between your sense of smell and your memory. Smell doesn't just evoke memories; it anchors them in emotion, linking past and present in a sensory flash.
In a 2016 study published in Brain Sciences, author Rachel S. Herz highlights how smell is not only a powerful trigger for memory, but plays an essential role in enhancing our well-being.
She found that smells linked to positive memories can boost positive emotions, reduce negative moods, curb cravings and lower stress, including markers of inflammation in the body.
So, how does a familiar scent transport you decades into the past? Here are three reasons why smell is so deeply tied to memory and emotion, and why it's important to make the most of this connection.
What makes smell so potent in triggering memory lies in its unique pathway to the brain. Unlike sight and sound, which can take a longer, more roundabout route to reach memory centers, smell has a direct passageway.
In a prior study, Herz describes how different senses (smell, sight and sound) trigger memories and emotions. She found that smells, like campfire or fresh-cut grass, brought up more emotional and powerful memories than when the same cues were presented visually or through sound.
Picture this — a high-speed train zooming past stations, heading straight for its destination. That's how your sense of smell directly works with the brain. The olfactory bulb, where scent signals are processed, sits close to the hippocampus and amygdala — the very regions responsible for memory and emotion. This proximity gives smell a VIP pass to your brain's most intimate spaces.
Herz also explains that smell-induced memories are often vivid and emotionally charged. Think of it like this — while sight might be the photograph in your mind's eye, smell is the living, breathing experience that takes you back to the moment as if it were happening right now.
Smell can resurrect entire chapters of your life with startling clarity. Imagine that your mind is a vast library, where memories gather dust on forgotten shelves. A specific smell acts like a librarian dusting off an old book, placing it in your hands before you even realize it's missing.
A 2023 review suggests that certain flavors and smells can vividly transport us back to specific moments in our lives, even when other details have long been forgotten.
Smells that are linked to childhood often have the ability to evoke powerful autobiographical memories that define your understanding of yourself today. This phenomenon is called the 'Proust Effect.'
Researchers highlight how the Proust effect also creates a sense of connection with others and gives life more meaning, reawakening moments that have otherwise faded into obscurity.
'The 'Proust phenomenon' from the eponymous literary anecdote where Marcel Proust took a bite of madeleine biscuit that had been dipped in Linden tea and was suddenly transported to a long forgotten moment in his childhood, occurs when an odor triggers the recollection of a meaningful past personal episode,' Herz explains in her 2016 study.
This sensory time travel is rooted in your brain's architecture. A 2012 study published in Neuropsychologia confirms how memories triggered by smells tend to be older, more emotional and feel more like time-travel compared to memories triggered by other senses.
Memories triggered by smell come steeped in emotional layers. The smell of rain-soaked earth, known as petrichor, offers a perfect example of this idea. For some, it brings comfort and nostalgia, stirring up memories of quiet afternoons after a summer storm in their childhood. Whereas, for others, that same scent might carry a tinge of sadness, perhaps reminding them of a time they felt loss or isolation.
This emotional potency isn't arbitrary. When your brain stores a memory, it doesn't just catalog the details — it renders the feelings too. It's likely that the more emotionally intense the experience, the more strongly the memory is imprinted.
So, the next time a familiar scent suddenly brings back a memory, take a moment to appreciate it. Your brain is opening a door to the past, letting you revisit stories and emotions that might have been forgotten.
Do you often feel nostalgic? Take this science-backed test to learn if you might benefit from being more grounded in the present: Nostalgia Scale
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNN
39 minutes ago
- CNN
SCOTUS orders judges to revisit decisions on transgender health plans, birth certificates in wake of blockbuster ruling
The Supreme Court on Monday tossed aside a handful of lower court rulings that sided with transgender Americans, requiring that judges in those cases revisit their decisions in the wake of a blockbuster ruling this month that upheld a ban on gender-affirming care for trans youth. The justices upended rulings that blocked state policies excluding coverage for gender-affirming care in state-sponsored health insurance plans. In a loss for the transgender Americans who sued, those decisions will now be reviewed again. The high court also upended an appeals court ruling that went against Oklahoma in a challenge to the state's effort to ban transgender residents from changing the sex designation on their birth certificates. Lower courts must now review the trio of cases again in light of the Supreme Court's major decision on June 18 that upheld Tennessee's ban on puberty blockers and hormone therapy for trans minors. The 6-3 ruling in US v. Skrmetti steered clear of discussion about other laws involving transgender Americans, but it also did little to protect them in other cases. The court ruled that Tennessee had not discriminated on the basis of sex, which gave the state far more room to regulate medical care. The court also held that the law did not discriminate on the basis of transgender status. This story is breaking and will be updated.
Yahoo
41 minutes ago
- Yahoo
Many People Actually Lose Muscle on a GLP-1. It's Not Too Hard to Avoid—Here's How.
MANY MEN STARTING GLP-1 medications like semaglutide or tirzepatide are trying to lose visceral fat. I've seen this in my work with clients as a dietitian. And targeting visceral fat is a good thing. That's because it's the kind of fat that wraps around your organs and raises your risk for heart disease, diabetes, and other health complications. But here's the thing: Unless you have the right plan, some of the weight you might lose on a GLP-1 might be hard-earned muscle. Recent research suggests that without lifestyle support, such as strength training and adequate protein intake, patients on GLP-1s can lose up to 40 percent of their total body weight, primarily from lean muscle mass rather than fat. Not only could that mean a loss of muscle mass, but a slower metabolism, too. (Not to mention a body composition recovery hill that sucks to climb.) But notice how above I mentioned the right plan? Well, here's that plan—for cutting visceral fat and keeping muscle. Think of your body like a team. GLP-1, a hormone, is your assistant coach that helps everything work together better. It helps you feel full faster, curbs your appetite, and keeps your blood sugar in check. Medications like semaglutide work by mimicking this hormone, lowering your drive to overeat and helping you manage your overall weight more effectively. Except in turning down the hunger signal, a GLP-1 med may also cause you to not consume enough of the right things. Namely protein. "It's criminal to put someone on a GLP-1 and not put them on a dietary plan," says Phil Vella, founder of Vita Bella Clinics, which operates over 35 weight-loss clinics across the U.S. "Protein is the single most important thing for them to [eat] when taking a GLP-1.' That's because protein is a major building block of muscle. Consume the right amount daily, and you maintain the muscle you have (and, depending on the conditions, grow more). Come up short and muscle loss can happen. The right plan involves a little math, a few adjustments, and some effort. That said, it'll reward you with greater strength and power. How do you know? Find out if that clinic has a registered dietitian on staff or can refer patients to one. Because the goal isn't just to lose weight. It's to keep what matters most while you're doing it. Aim for 1.6 to 2.0 grams of protein per kilogram of body weight per day (which is roughly 0.8 to 1 gram per pound). For a 175-pound guy, that's approximately 140 to 160 grams daily. And don't dump it all into one meal. Distribute your protein evenly, targeting 30 to 40 grams per meal. Leucine—an essential amino acid found in meat, dairy, and whey protein—triggers muscle growth. Prioritize proteins like eggs, fish, Greek yogurt, and beef. For plant-based eaters, be strategic and combine grains and legumes, or consider adding tofu to achieve a complete amino acid profile. Protein shakes, cottage cheese, high-protein yogurts, and foods with added protein and fiber can help bridge the gap, especially when your hunger is low. I love items that have 20-plus grams of protein and 5-plus grams of fiber. Muscle is a "use it or lose it" type of asset. Train with intention at least three times a week. Prioritize resistance training to signal to your body: "Hey, this tissue is still needed.' You Might Also Like The Best Hair Growth Shampoos for Men to Buy Now 25 Vegetables That Are Surprising Sources of Protein
Yahoo
42 minutes ago
- Yahoo
industryGENOME Unveils Groundbreaking Clinical Trial PAO Market Map Report, Powered by AI-Assisted Market Intelligence
TAMPA, Fla., June 30, 2025--(BUSINESS WIRE)--industryGENOME, a cutting-edge analytics firm specializing in granular precision insights, has released its first-ever Clinical Trial Patient Access Organization (PAO) Market Map Report, developed in collaboration with WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, and Crosstree. This report offers an unparalleled bottom-up analysis of the PAO sector, using AI-powered classification models to predict private company revenue and stratify market estimates across geographies, subsidiaries, and specialized capabilities. Transforming Industry Analysis with AI-Assisted Precision Leveraging its proprietary Industry Capabilities Classification System (ICCS®), industryGENOME provides a standardized and globally applicable framework for categorizing businesses. The ICCS® methodology enhances financial analysis, investment decision-making, and strategy development across the life sciences and healthcare industries. The report was developed in close collaboration with WCG, which played a pivotal role in identifying global industry participants to ensure the most comprehensive market representation. Crosstree assisted industryGENOME in industry classification quality assurance and predictive modeling, enhancing the precision of market insights. "This report is the most sophisticated analysis of the clinical trial PAO sector to date," said Shane Senior, Managing Director at Crosstree. "industryGENOME's AI-driven predictive engines achieve 85% classification accuracy, surpassing human classifiers, and ensuring the most precise industry intelligence for investors and market participants. The ability to scale this precision across large data sets is unprecedented." Key Findings from the Clinical Trial PAO Market Map Report Total Market Revenue: $14.95 billion Industry Participants: Over 3,000 global Patient Access Organizations with detailed company profiles for each Industry Stratification: Freestanding, Mobile, Virtual, Provider Embedded, and Service Embedded Sites Top Industry Players: Velocity, IQVIA, PPD, AES, CenExel Clinical Research, ERG, Javara Advanced Market Mapping: AI-assisted data collection and synthesis for high-fidelity revenue estimates allowing for "sum-of-the-parts" bottom-up market sizing Geo-Stratification Analysis: The United States leads with $10.6 billion in revenue, followed by the UK, Germany, and Australia Why This Report Sets a New Standard industryGENOME's bottom-up methodology, empowered by machine learning and predictive analytics, provides unprecedented insights into the PAO sector. The firm's mapped markets process, which identifies, collects, and analyzes micro-industry data, ensures highly precise revenue estimates, critical for investors, procurement specialists, and drug developers seeking strategic market positioning. Access the Report Today To access the Clinical Trial PAO Market Map Report, visit or contact Jordan Schiding at About industryGENOME industryGENOME is a market intelligence platform for the Health Sciences industry that continuously collects and analyzes millions of data points on pharma services companies, investors, deals, valuations, research, conferences, and news. It produces bottom-up market research reports and company profiles by combining AI with the expertise of industry investment professionals. The platform is distinguished by a proprietary, highly granular taxonomy that categorizes industry participant capabilities through defined relationships. This classification system delivers clean, precise, and actionable insights on the Health Sciences market. Using AI technologies—including natural language processing, machine translation, and supervised machine learning—industryGENOME classifies and curates data. In partnership with Crosstree, the platform trains its classification algorithm for accuracy and precision. Together, they are mapping the Health Sciences market one company at a time to deliver detailed, bottom-up industry segment insights. Learn more at About Crosstree Crosstree is a distinguished boutique investment banking firm focused exclusively on the needs of middle-market companies within three subsectors of the life sciences and healthcare industries: pharmaceutical services, diagnostics and tools, and digital health. Since 2004, Crosstree has advised on more completed transactions in these collective subsectors than any other investment bank. The firm provides clients a full suite of advisory and capital raising services, including both buy-and sell-side mergers and acquisitions advisory, private capital raising, strategic advisory, and valuations. Crosstree's narrow industry focus provides clients the expertise common of a bulge-bracket investment banking firm to middle-market companies and investors, with unparalleled industry insights, well-established strategic relationships across the globe and superior access to capital markets. From our offices in Tampa, Florida, Crosstree has advised clients throughout North America, Europe, India, China, Latin America, and Australia on transactions ranging from $25 million to more than $1 billion. About WCG WCG is at the forefront of accelerating clinical research worldwide, serving as the trusted and preferred partner to biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and site partners. Offering a unique combination of expertise, next-generation data and insights, and tech-enabled solutions, WCG reduces complexity and optimizes study operations and outcomes while maintaining the highest standards of human participant protection. For more than 55 years, WCG has maintained a relentless commitment to efficiency, safety, and impact, empowering clinical trials to deliver life-improving therapies swiftly. For more information, please visit or follow us on LinkedIn or X @WCGClinical. View source version on Contacts industryGENOME and Crosstree Media Contact: Hillary McCutcheonFreshwater Marketing813.992.1470hillary@ WCG Media Contact: Carmin Gade, PhDChief Marketing Officer, WCG484.351.9959cgade@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data